{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:33:08Z","timestamp":1786116788690,"version":"build-2736575974"},"reference-count":110,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.05.010","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:13:02Z","timestamp":1786018382000},"page":"515-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Psychotropic Medications During Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Edwin R.","family":"Raffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Nonacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2026.05.010_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.295.5.499","article-title":"Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment","volume":"295","author":"Cohen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.05.010_bib3","first-page":"1","article-title":"The expert consensus guideline series. Treatment of depression in women","volume":"Spec No","author":"Altshuler","year":"2001","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clp.2026.05.010_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/pds.3462","article-title":"Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clp.2026.05.010_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1176\/ajp.153.5.592","article-title":"Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines","volume":"153","author":"Altshuler","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib6","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4088\/JCP.v67n0817","article-title":"Exposure to mirtazapine during pregnancy: a prospective comparative study of birth outcomes","volume":"67","author":"Djulus","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/070674370404901103","article-title":"Perinatal risks of untreated depression during pregnancy","volume":"49","author":"Bonari","year":"2004","journal-title":"Can J Psychiatr"},{"key":"10.1016\/j.clp.2026.05.010_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/AOG.0b013e3181ba0632","article-title":"The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists","volume":"114","author":"Yonkers","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.010_bib9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jad.2007.12.228","article-title":"Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study","volume":"110","author":"Freeman","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clp.2026.05.010_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1440-1614.2002.t01-4-01015.x","article-title":"Cognitive therapy of depression","volume":"36","author":"King","year":"2002","journal-title":"Aust N Z J Psychiatr"},{"key":"10.1016\/j.clp.2026.05.010_bib11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1176\/ajp.154.7.1028","article-title":"Interpersonal psychotherapy for depressed antepartum women: a pilot study","volume":"154","author":"Spinelli","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib12","series-title":"Interpersonal psychotherapy for depression","author":"Weissman","year":"2015"},{"key":"10.1016\/j.clp.2026.05.010_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jad.2011.01.003","article-title":"Generalized anxiety disorder: course and risk factors in pregnancy","volume":"131","author":"Buist","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clp.2026.05.010_bib14","first-page":"266","article-title":"Panic attack-associated placental abruption: a case report","volume":"50","author":"Cohen","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000077745","article-title":"Reintroduction of antidepressant therapy across pregnancy in women who previously discontinued treatment","volume":"73","author":"Cohen","year":"2004","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.clp.2026.05.010_bib16","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation","volume":"164","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7085","article-title":"Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study","volume":"345","author":"Bod\u00e9n","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.clp.2026.05.010_bib18","series-title":"Massachusetts general hospital handbook of general hospital psychiatry","article-title":"Psychiatric illness during pregnancy and the postpartum period","author":"Hogan","year":"2018"},{"key":"10.1016\/j.clp.2026.05.010_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1523-536X.1992.tb00670.x","article-title":"Treatment and outcomes of psychotic patients during pregnancy and childbirth","volume":"19","author":"Spielvogel","year":"1992","journal-title":"Birth"},{"key":"10.1016\/j.clp.2026.05.010_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jama.282.13.1264","article-title":"Pharmacologic treatment of depression during pregnancy","volume":"282","author":"Wisner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.05.010_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.siny.2013.11.007","article-title":"Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy","volume":"19","author":"Ornoy","year":"2014","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.clp.2026.05.010_bib22","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.010_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1798","article-title":"Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design","volume":"350","author":"Furu","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.clp.2026.05.010_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/AOG.0b013e318220edcc","article-title":"Selective serotonin reuptake inhibitors and risk for major congenital anomalies","volume":"118","author":"Malm","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.010_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1167870","article-title":"Infant exposure to fluvoxamine through placenta and human milk: a case series - a contribution from the ConcePTION project","volume":"14","author":"Monfort","year":"2023","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.clp.2026.05.010_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.ede.0000239581.76793.ae","article-title":"Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations","volume":"17","author":"Wogelius","year":"2006","journal-title":"Epidemiology"},{"key":"10.1016\/j.clp.2026.05.010_bib28","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1056\/NEJMoa066584","article-title":"National birth Defects Prevention Study. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects","volume":"356","author":"Alwan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.010_bib29","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.010_bib30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1017\/S1092852900014012","article-title":"Pregnancy exposure to serotonin reuptake inhibitors and the risk of spontaneous abortions","volume":"13","author":"Gentile","year":"2008","journal-title":"CNS Spectr"},{"key":"10.1016\/j.clp.2026.05.010_bib31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.2007.07060879","article-title":"Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy","volume":"165","author":"Einarson","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib32","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.010_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1542\/peds.113.2.368","article-title":"Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior","volume":"113","author":"Zeskind","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2026.05.010_bib34","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","article-title":"Outcomes of prenatal antidepressant exposure","volume":"159","author":"Simon","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.clp.2026.05.010_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294996","article-title":"Maternal exposure to SSRIs or SNRIs and the risk of congenital abnormalities in offspring: a systematic review and meta-analysis","volume":"18","author":"Huang","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clp.2026.05.010_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40272-023-00561-2","article-title":"Benefits and risks of antidepressant drugs during pregnancy: a systematic review of meta-analyses","volume":"25","author":"Desaunay","year":"2023","journal-title":"Paediatr Drugs"},{"issue":"1","key":"10.1016\/j.clp.2026.05.010_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41380-024-02697-0","article-title":"Safety of psychotropic medications in pregnancy: an umbrella review","volume":"30","author":"Fabiano","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.clp.2026.05.010_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13367","article-title":"Neonatal outcome and adaption after in utero exposure to antidepressants: a systematic review and meta-analysis","volume":"145","author":"Kautzky","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.clp.2026.05.010_bib39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0000000000004538","article-title":"Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data meta-analysis","volume":"138","author":"Vlenterie","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.010_bib40","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1001\/jama.1993.03500170076037","article-title":"Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)","volume":"269","author":"Pastuszak","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.05.010_bib41","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00737-004-0057-5","article-title":"The impact of depression and fluoxetine treatment on obstetrical outcome","volume":"7","author":"Suri","year":"2004","journal-title":"Arch Wom Ment Health"},{"key":"10.1016\/j.clp.2026.05.010_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.clp.2026.05.010_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.010_bib45","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clp.2026.05.010_bib46","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.05.010_bib47","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1542\/peds.2006-3037","article-title":"Risk factors for persistent pulmonary hypertension of the newborn","volume":"120","author":"Hern\u00e1ndez-D\u00edaz","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2026.05.010_bib48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0895-4356(92)90149-H","article-title":"Self-reported depression and negative pregnancy outcomes","volume":"45","author":"Steer","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.clp.2026.05.010_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11920-022-01372-x","article-title":"Selective serotonin reuptake inhibitors (SSRIs) in pregnancy: an updated review on risks to mother, fetus, and child","volume":"24","author":"Lebin","year":"2022","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.clp.2026.05.010_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":"Neurodevelopment of children exposed in utero to antidepressant drugs","volume":"336","author":"Nulman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.010_bib51","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"Nulman","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapediatrics.2015.3356","article-title":"Antidepressant use during pregnancy and the risk of autism spectrum disorder in children","volume":"170","author":"Boukhris","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2026.05.010_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaac.2016.02.013","article-title":"Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study","volume":"55","author":"Malm","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","article-title":"Use of antidepressants during pregnancy and risk of attention-deficit\/hyperactivity disorder in the offspring","volume":"31","author":"Figueroa","year":"2010","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.clp.2026.05.010_bib55","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","article-title":"Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism","volume":"369","author":"Hviid","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.010_bib56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S53009","article-title":"Antidepressant exposure in pregnancy and risk of autism spectrum disorders","volume":"5","author":"S\u00f8rensen","year":"2013","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.clp.2026.05.010_bib57","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.4088\/JCP.17f11916","article-title":"Antidepressant exposure during pregnancy and risk of autism in the offspring: do the new studies add anything new?","volume":"78","author":"Andrade","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib58","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapediatrics.2017.0124","article-title":"Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis","volume":"171","author":"Mezzacappa","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2026.05.010_bib59","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2022.4268","article-title":"Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children","author":"Suarez","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.clp.2026.05.010_bib60","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12965","article-title":"Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: a systematic review","volume":"81","author":"Rommel","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.clp.2026.05.010_bib61","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311x00026619","article-title":"Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review","volume":"36","author":"Araujo","year":"2020","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"12","key":"10.1016\/j.clp.2026.05.010_bib62","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamapsychiatry.2023.3161","article-title":"Prenatal antidepressant exposure and offspring brain morphologic trajectory","volume":"80","author":"Koc","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12884-017-1334-4","article-title":"Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study","volume":"17","author":"Heller","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.clp.2026.05.010_bib64","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/AOG.0000000000001200","article-title":"Postpartum hemorrhage and use of serotonin reuptake inhibitor antidepressants in pregnancy","volume":"127","author":"Hanley","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.010_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4877","article-title":"Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States","volume":"347","author":"Palmsten","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.clp.2026.05.010_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bcpt.12497","article-title":"First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review","volume":"118","author":"Lassen","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"12","key":"10.1016\/j.clp.2026.05.010_bib67","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2020.2453","article-title":"Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects","volume":"77","author":"Anderson","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114756","article-title":"Exposure to selective noradrenalin reuptake inhibitors during the first trimester of pregnancy and risk of congenital malformations: a meta-analysis of cohort studies","volume":"316","author":"Lou","year":"2022","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clp.2026.05.010_bib69","article-title":"Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study","volume":"368","author":"Huybrechts","year":"2020","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.clp.2026.05.010_bib70","article-title":"Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: a nationwide cohort study in Denmark and Sweden","volume":"18","author":"Ankarfeldt","year":"2021","journal-title":"Public Libr Sci Med"},{"issue":"11","key":"10.1016\/j.clp.2026.05.010_bib71","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/phar.2628","article-title":"Comparing newborn outcomes after prenatal exposure to individual antidepressants: a retrospective cohort study","volume":"41","author":"Marks","year":"2021","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clp.2026.05.010_bib72","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4088\/JCP.15m10506","article-title":"Prenatal psychostimulant and antidepressant exposure and risk of hypertensive disorders of pregnancy","volume":"77","author":"Newport","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib74","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ajog.2004.09.027","article-title":"Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study","volume":"192","author":"Chun-Fai-Chan","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.05.010_bib75","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pds.1296","article-title":"Bupropion in pregnancy and the prevalence of congenital malformations","volume":"16","author":"Cole","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.clp.2026.05.010_bib76","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ntr\/nty055","article-title":"Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy","volume":"21","author":"Turner","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.clp.2026.05.010_bib77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0447.2000.tb10945.x","article-title":"Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children\/adolescents and in the elderly","volume":"101","author":"Emslie","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clp.2026.05.010_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S003329171000022X","article-title":"Should we stop using tricyclic antidepressants in pregnancy?","volume":"41","author":"Pariante","year":"2011","journal-title":"Psychol Med"},{"key":"10.1016\/j.clp.2026.05.010_bib79","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.4088\/JCP.09com05529","article-title":"No decision is without risk","volume":"70","author":"Suri","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.psc.2010.02.001","article-title":"Treatment of mood disorders during pregnancy and postpartum","volume":"33","author":"Cohen","year":"2010","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.clp.2026.05.010_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.116038","article-title":"Prenatal antidepressant use and risk of congenital malformations: a population-based cohort study","volume":"339","author":"Chan","year":"2024","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clp.2026.05.010_bib82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.euroneuro.2025.05.001","article-title":"Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: a propensity score-weighted population-based cohort study in 2003-2018","volume":"96","author":"Lee","year":"2025","journal-title":"Eur Neuropsychopharmacol"},{"issue":"PCC","key":"10.1016\/j.clp.2026.05.010_bib83","first-page":"13r01525","article-title":"A review of therapeutic uses of mirtazapine in psychiatric and medical conditions","volume":"15","author":"Alam","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.clp.2026.05.010_bib84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.euroneuro.2015.06.014","article-title":"Mirtazapine in pregnancy and lactation: a systematic review","volume":"26","author":"Smit","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.clp.2026.05.010_bib85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/acps.13431","article-title":"Mirtazapine exposure in pregnancy and fetal safety: a nationwide cohort study","volume":"145","author":"Ostenfeld","year":"2022","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.clp.2026.05.010_bib86","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13749","article-title":"Mirtazapine in pregnancy and lactation: a systematic review of adverse outcomes","volume":"151","author":"Ostenfeld","year":"2025","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clp.2026.05.010_bib87","doi-asserted-by":"crossref","DOI":"10.1097\/MJT.0000000000000698","article-title":"Low-dose mirtazapine in major depression developed after hyperemesis gravidarum: a case series","author":"Uguz","year":"2018","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.clp.2026.05.010_bib88","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/070674370304800207","article-title":"A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy","volume":"48","author":"Einarson","year":"2003","journal-title":"Can J Psychiatr"},{"issue":"1","key":"10.1016\/j.clp.2026.05.010_bib89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/JCP.0000000000001630","article-title":"Reproductive safety of trazodone after maternal exposure in early pregnancy: a comparative ENTIS cohort study","volume":"43","author":"Dao","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clp.2026.05.010_bib90","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1176\/ajp.132.5.529","article-title":"Cardiovascular malformations with lithium use during pregnancy","volume":"132","author":"Weinstein","year":"1975","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib91","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","article-title":"Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy","volume":"162","author":"Newport","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.clp.2026.05.010_bib92","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S2215-0366(18)30180-9","article-title":"Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies","volume":"5","author":"Munk-Olsen","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.clp.2026.05.010_bib93","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","article-title":"Lithium use in pregnancy and the risk of cardiac malformations","volume":"376","author":"Patorno","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clp.2026.05.010_bib94","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00737-022-01234-8","article-title":"Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study","volume":"25","author":"Sagu\u00e9-Vilavella","year":"2022","journal-title":"Arch Wom Ment Health"},{"key":"10.1016\/j.clp.2026.05.010_bib95","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1212\/01.wnl.0000304343.45104.d6","article-title":"Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy","volume":"70","author":"Holmes","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clp.2026.05.010_bib96","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1212\/WNL.0b013e31821ccd18","article-title":"Final results from 18 years of the international lamotrigine pregnancy registry","volume":"76","author":"Cunnington","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.clp.2026.05.010_bib97","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0000000000002540","article-title":"Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies","volume":"86","author":"Dolk","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clp.2026.05.010_bib98","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hern\u00e1ndez-D\u00edaz","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.clp.2026.05.010_bib99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","article-title":"Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis","volume":"31","author":"Pariente","year":"2017","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.clp.2026.05.010_bib100","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ana.26561","article-title":"Comparative safety of antiseizure medication monotherapy for major malformations","volume":"93","author":"Cohen","year":"2023","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.clp.2026.05.010_bib101","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamaneurol.2024.0258","article-title":"Risk of major congenital malformations and exposure to antiseizure medication monotherapy","volume":"81","author":"Battino","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.clp.2026.05.010_bib102","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"8","author":"Bromley","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2026.05.010_bib103","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Increased rate of major malformations in offspring exposed to valproate during pregnancy","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clp.2026.05.010_bib104","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clp.2026.05.010_bib105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioral functioning at age 6 years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.clp.2026.05.010_bib106","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.05.010_bib107","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejogrb.2014.08.013","article-title":"Potential maternal symptomatic benefit of gabapentin and review of its safety in pregnancy","volume":"181","author":"Guttuso","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"9","key":"10.1016\/j.clp.2026.05.010_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003322","article-title":"Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US medicaid analytic eXtract dataset","volume":"17","author":"Patorno","year":"2020","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.clp.2026.05.010_bib109","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ppe.13086","article-title":"Risks of congenital malformations and neonatal intensive care unit admissions with gabapentin use in pregnancy: a cohort study and scoping review with meta-analysis","volume":"38","author":"Desrochers","year":"2024","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"11","key":"10.1016\/j.clp.2026.05.010_bib110","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209279","article-title":"Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM","volume":"102","author":"Pack","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.clp.2026.05.010_bib111","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.clp.2026.05.010_bib112","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM199103073241006","article-title":"Spina bifida in infants of women treated with carbamazepine during pregnancy","volume":"324","author":"Rosa","year":"1991","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clp.2026.05.010_bib113","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","article-title":"Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study","volume":"90","author":"Hernandez-Diaz","year":"2018","journal-title":"Neurology"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:15:05Z","timestamp":1786018505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000588"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.010","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Psychotropic Medications During Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}